Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.200
+0.010 (0.46%)
At close: Jan 30, 2026, 4:00 PM EST
2.242
+0.042 (1.92%)
After-hours: Jan 30, 2026, 5:15 PM EST
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $4.93 million as of January 30, 2026. Its market cap has decreased by -59.85% in one year.
Market Cap
4.93M
Enterprise Value
-883.84K
1-Year Change
-59.85%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $4.93M, a decrease of -89.71%. That is a compound annual growth rate of -39.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 4.93M | -3.19% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 5.66M |
| Acurx Pharmaceuticals | 5.57M |
| Abpro Holdings | 5.27M |
| Cyclerion Therapeutics | 5.25M |
| Xenetic Biosciences | 5.13M |
| Aspire Biopharma Holdings | 5.05M |
| Decoy Therapeutics | 4.98M |
| GeoVax Labs | 4.75M |